LetterLetter
Dr. Conway et al reply
Richard Conway, Elisabeth Brouwer, Kornelis S.M. van der Geest, Sarah L. Mackie, Puja Mehta, Michael Putman, Philip Robinson and Sebastian Sattui
The Journal of Rheumatology October 2021, jrheum.210913; DOI: https://doi.org/10.3899/jrheum.210913
Richard Conway
Department of Rheumatology, St James's Hospital, Dublin, Ireland; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, and Department of Rheumatology, University College London Hospital (UCLH) NHS Trust, London, UK; Medical College of Wisconsin, Milwaukee, Wisconsin, USA; University of Queensland Faculty of Medicine, Brisbane, Australia; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.L. Mackie, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Email: s.l.mackie@leeds.ac.uk.
Elisabeth Brouwer
Department of Rheumatology, St James's Hospital, Dublin, Ireland; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, and Department of Rheumatology, University College London Hospital (UCLH) NHS Trust, London, UK; Medical College of Wisconsin, Milwaukee, Wisconsin, USA; University of Queensland Faculty of Medicine, Brisbane, Australia; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.L. Mackie, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Email: s.l.mackie@leeds.ac.uk.
Kornelis S.M. van der Geest
Department of Rheumatology, St James's Hospital, Dublin, Ireland; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, and Department of Rheumatology, University College London Hospital (UCLH) NHS Trust, London, UK; Medical College of Wisconsin, Milwaukee, Wisconsin, USA; University of Queensland Faculty of Medicine, Brisbane, Australia; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.L. Mackie, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Email: s.l.mackie@leeds.ac.uk.
Sarah L. Mackie
Department of Rheumatology, St James's Hospital, Dublin, Ireland; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, and Department of Rheumatology, University College London Hospital (UCLH) NHS Trust, London, UK; Medical College of Wisconsin, Milwaukee, Wisconsin, USA; University of Queensland Faculty of Medicine, Brisbane, Australia; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.L. Mackie, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Email: s.l.mackie@leeds.ac.uk.
Puja Mehta
Department of Rheumatology, St James's Hospital, Dublin, Ireland; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, and Department of Rheumatology, University College London Hospital (UCLH) NHS Trust, London, UK; Medical College of Wisconsin, Milwaukee, Wisconsin, USA; University of Queensland Faculty of Medicine, Brisbane, Australia; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.L. Mackie, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Email: s.l.mackie@leeds.ac.uk.
Michael Putman
Department of Rheumatology, St James's Hospital, Dublin, Ireland; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, and Department of Rheumatology, University College London Hospital (UCLH) NHS Trust, London, UK; Medical College of Wisconsin, Milwaukee, Wisconsin, USA; University of Queensland Faculty of Medicine, Brisbane, Australia; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.L. Mackie, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Email: s.l.mackie@leeds.ac.uk.
Philip Robinson
Department of Rheumatology, St James's Hospital, Dublin, Ireland; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, and Department of Rheumatology, University College London Hospital (UCLH) NHS Trust, London, UK; Medical College of Wisconsin, Milwaukee, Wisconsin, USA; University of Queensland Faculty of Medicine, Brisbane, Australia; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.L. Mackie, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Email: s.l.mackie@leeds.ac.uk.
Sebastian Sattui
Department of Rheumatology, St James's Hospital, Dublin, Ireland; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, UK; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, and Department of Rheumatology, University College London Hospital (UCLH) NHS Trust, London, UK; Medical College of Wisconsin, Milwaukee, Wisconsin, USA; University of Queensland Faculty of Medicine, Brisbane, Australia; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.L. Mackie, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Email: s.l.mackie@leeds.ac.uk.

Abstract
We thank Sauret et al1 for their interest in our systematic literature review that explored potential diagnostic confusion between giant cell arteritis (GCA) and the coronavirus disease 2019 (COVID-19). This was a particularly important consideration during the early months of the COVID-19 pandemic, when community testing for SARS-CoV-2 was limited and diagnostic tests for GCA were restricted or unavailable due to redeployment of staff.2
In this issue
The Journal of Rheumatology
Vol. 50, Issue 9
1 Sep 2023
Dr. Conway et al reply
Richard Conway, Elisabeth Brouwer, Kornelis S.M. van der Geest, Sarah L. Mackie, Puja Mehta, Michael Putman, Philip Robinson, Sebastian Sattui
The Journal of Rheumatology Oct 2021, jrheum.210913; DOI: 10.3899/jrheum.210913